Tamoxifen for adults with hepatocellular carcinoma
Objectives To evaluate the benefits and harms of tamoxifen or tamoxifen plus any other
anticancer drugs compared with no intervention, placebo, any type of standard care, or …
anticancer drugs compared with no intervention, placebo, any type of standard care, or …
[HTML][HTML] Therapeutic value of estrogen receptor α in hepatocellular carcinoma based on molecular mechanisms
X Meng, X Liu - Journal of Clinical and Translational …, 2021 - pmc.ncbi.nlm.nih.gov
The incidence of hepatocellular carcinoma (HCC) is significantly lower in women than men,
implying that estrogen receptors (ERs) may play an important role in this sex dimorphism …
implying that estrogen receptors (ERs) may play an important role in this sex dimorphism …
Association between IL-10 gene polymorphisms (− 1082 A/G,-819 T/C,-592 A/C) and hepatocellular carcinoma: a meta-analysis and trial sequential analysis
Background The carcinogenesis of hepatocellular carcinoma is complicated, and genetic
factor may have the role in the malignant transformation of liver cells. IL-10 gene …
factor may have the role in the malignant transformation of liver cells. IL-10 gene …
Gene therapy for people with hepatocellular carcinoma
Background Hepatocellular carcinoma is the most common type of liver cancer, accounting
for 70% to 85% of individuals with primary liver cancer. Gene therapy, which uses genes to …
for 70% to 85% of individuals with primary liver cancer. Gene therapy, which uses genes to …
Tamoxifen for hepatocellular carcinoma
MRMR Stockler, M Findlay, GGV Vijuk… - Cochrane Database …, 1996 - cochranelibrary.com
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The
primary objective is to conduct a systematic review of the published literature to assess the …
primary objective is to conduct a systematic review of the published literature to assess the …